Evidence map›Paper›PMID 24012677›Full record

ArticleThe American journal of pathology2013

Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins.

Jibing Yang, Sarah E Wheeler, Miranda Velikoff, Kathryn R Kleaveland, Michael J LaFemina, James A Frank, Harold A Chapman, Paul J Christensen, Kevin K Kim

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through αAmerican journal of respiratory cell and molecular biology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jibing YangDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Sarah E WheelerDepartment of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, California.
Miranda VelikoffDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Kathryn R KleavelandDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Michael J LaFeminaDepartment of Medicine, San Francisco VA Medical Center, University of California, San Francisco, California.
James A FrankDepartment of Medicine, San Francisco VA Medical Center, University of California, San Francisco, California.
Harold A ChapmanDepartment of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, California.
Paul J ChristensenDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Kevin K KimDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: kevkim@med.umich.edu.
University of Michigan–Ann Arbor · USUniversity of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

REGULATION OF INTEGRIN FUNCTIONR01HL044712 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAPMAN, HAROLD A · 1991 to 2014
$4.8M
Type I collagen signaling in lung injury and fibrosisR01HL108904 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, KEVIN KEEWOUN · 2012 to 2020
$3.5M
Regulation of alveolar epithelial barrier function by claudinsR01HL088440 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI FRANK, JAMES A · 2007 to 2011
$2.3M
Alpha3Beta Integrin Function in Epithelial-Mesenchymal Transition and FibrosisK08HL085290 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, KEVIN KEEWOUN · 2007 to 2011
$625k
Regulation of alveolar barrier function by claudinsR56HL088440 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI FRANK, JAMES A · 2013 to 2013
$380k
NHLBI NIH HHS K08 HL085290NHLBI NIH HHS R01 HL044712NHLBI NIH HHS R01 HL088440NHLBI NIH HHS R01 HL108904NHLBI NIH HHS R01 HL44712NHLBI NIH HHS R56 HL088440
6 · The paper itself

Abstract

Fibrosis is characterized by accumulation of activated fibroblasts and pathological deposition of fibrillar collagens. Activated fibroblasts overexpress matrix proteins and release factors that promote further recruitment of activated fibroblasts, leading to progressive fibrosis. The contribution of epithelial cells to this process remains unknown. Epithelium-directed injury may lead to activation of epithelial cells with phenotypes and functions similar to activated fibroblasts. Prior reports that used a reporter gene fate-mapping strategy are limited in their ability to investigate the functional significance of epithelial cell-derived mesenchymal proteins during fibrogenesis. We found that lung epithelial cell-derived collagen I activates fibroblast collagen receptor discoidin domain receptor-2, contributes significantly to fibrogenesis, and promotes resolution of lung inflammation. Alveolar epithelial cells undergoing transforming growth factor-β-mediated mesenchymal transition express several other secreted profibrotic factors and are capable of activating lung fibroblasts. These studies provide direct evidence that activated epithelial cells produce mesenchymal proteins that initiate a cycle of fibrogenic effector cell activation, leading to progressive fibrosis. Therapy targeted at epithelial cell production of type I collagen offers a novel pathway for abrogating this progressive cycle and for limiting tissue fibrosis but may lead to sustained lung injury/inflammation.

Indexed as

Alveolar Epithelial CellsAnimalsCollagen Type ICollagen Type I, alpha 1 ChainFibroblastsFibrosisGene DeletionHumansMesodermMiceOrgan SpecificityPneumoniaProteinsReproducibility of ResultsCollagen Type ICollagen Type I, alpha 1 ChainProteins

Identifiers

PMID24012677
PMCPMC3814683
OpenAlexW2102025905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.